Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Share Price
Equities
300255
CNE1000016C2
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 41.81 CNY | -0.21% |
|
-9.13% | -32.67% |
| Capitalization | 38.43B 5.64B 4.85B 4.44B 4.21B 7.76B 544B 7.89B 53.11B 20.58B 257B 21.18B 20.73B 897B | P/E ratio 2024 |
-74x | P/E ratio 2025 | -159x |
|---|---|---|---|---|---|
| Enterprise value | 40.86B 6B 5.16B 4.72B 4.48B 8.25B 578B 8.39B 56.48B 21.89B 274B 22.53B 22.05B 954B | EV / Sales 2024 |
20.1x | EV / Sales 2025 | 68x |
| Free-Float |
50.4% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -0.21% | ||
| 1 week | -9.13% | ||
| Current month | +1.09% | ||
| 1 month | -4.26% | ||
| 3 months | -3.15% | ||
| 6 months | -26.58% | ||
| Current year | -32.67% |
| 1 week | 40.8 |  | 46.25 |
| 1 month | 38.92 | | 47 |
| Current year | 35.13 | | 64.5 |
| 1 year | 25.26 | | 71.71 |
| 3 years | 4.3 | | 71.71 |
| 5 years | 4.3 | | 71.71 |
| 10 years | 3.88 | | 71.71 |
| Manager | Title | Age | Since |
|---|---|---|---|
Xiao Dong Gao
CEO | Chief Executive Officer | 53 | 12/05/2019 |
Xiao Hua Yue
DFI | Director of Finance/CFO | 55 | 05/11/2023 |
Xiao Chen
LAW | General Counsel | 45 | 31/08/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Xiang Jun Wang
BRD | Director/Board Member | 61 | 29/12/2021 |
De Ying Cao
BRD | Director/Board Member | 67 | 07/08/2011 |
Xiao Dong Gao
CHM | Chairman | 53 | 04/06/2024 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.21% | -9.13% | +64.03% | +742.94% | 5.64B | |
| -9.82% | -11.66% | +5.95% | -15.76% | 64.06B | |
| +2.87% | -1.99% | +48.04% | +167.90% | 50.94B | |
| -2.33% | +38.60% | +38.60% | +38.60% | 42.87B | |
| +2.57% | +0.14% | -59.18% | -67.58% | 33.4B | |
| -0.54% | -3.05% | +52.81% | -37.17% | 28.33B | |
| -1.90% | -9.02% | +93.52% | -61.61% | 19.09B | |
| -0.13% | -5.11% | +50.36% | +49.60% | 19.02B | |
| -0.37% | -9.81% | +50.80% | +109.97% | 17.79B | |
| +0.41% | -0.73% | +41.10% | +82.73% | 15.96B | |
| Average | -0.96% | -5.66% | +38.60% | +100.96% | 29.71B | |
| Weighted average by Cap. | -1.86% | -6.00% | +29.17% | +44.17% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.03B 151M 130M 119M 113M 208M 14.59B 212M 1.42B 552M 6.9B 568M 556M 24.06B | 875M 129M 110M 101M 95.97M 177M 12.38B 180M 1.21B 469M 5.86B 482M 472M 20.42B |
| Net income | -249M -36.65M -31.49M -28.81M -27.36M -50.38M -3.53B -51.23M -345M -134M -1.67B -138M -135M -5.82B | -358M -52.57M -45.17M -41.33M -39.25M -72.27M -5.06B -73.5M -495M -192M -2.4B -197M -193M -8.35B |
| Net Debt | 2.31B 339M 291M 266M 253M 465M 32.62B 473M 3.19B 1.23B 15.43B 1.27B 1.24B 53.79B | 2.44B 358M 308M 281M 267M 492M 34.49B 501M 3.37B 1.31B 16.32B 1.34B 1.32B 56.88B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/05/26 | 41.81 ¥ | -0.21% | 11,963,200 |
| 15/05/26 | 41.90 ¥ | -1.43% | 16,533,840 |
| 14/05/26 | 42.51 ¥ | -6.84% | 23,635,600 |
| 13/05/26 | 45.63 ¥ | +3.19% | 21,264,820 |
| 12/05/26 | 44.22 ¥ | -3.89% | 20,912,890 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Equities
- 300255 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition